Organon & Co (OGN)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Kevin Ali
Employees:
10,000
30 HUDSON STREET, FL 33, JERSEY CITY, NJ 07302
551-430-6000

Organon & Co. develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. It also offers cardiovascular products, consisting of several cholesterol-modifying medicines. The company sells its products primarily to drug wholesalers and retailers, hospitals, and government agencies.

Data derived from most recent annual or quarterly report
Market Cap 2.893 Billion Shares Outstanding255.568 Million Avg 30-day Volume 5.049 Million
P/E Ratio7.6072 Dividend Yield8.0645 EPS0.23
Price to Revenue0.7236 Debt to Equity-14.6927 EBITDA1.426 Billion
Price to Book Value0.0 Operating Margin20.6341 Enterprise Value12.69 Billion
Current Ratio1.626 EPS Growth-0.42 Quick Ratio0.828
1 Yr BETA 0.9074 52-week High/Low 30.51 / 10.91 Profit Margin9.5122
Operating Cash Flow Growth4.8589 Free Cash Flow to Firm (FCFF) TTM 574.713 Million Free Cash Flow to Equity (FCFE) TTM1.28 Billion
Altman Z-Score1.3155
Earnings Report2024-02-15

Are you looking for this stock instead?

View SEC Filings from OGN instead.

View recent insider trading info

Organon & Co YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding OGN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding OGN

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-06-13 by OZUAH PHILIP
  • 4: filed on 2023-06-13 by MCGARRY MARTHA E
  • 4: filed on 2023-06-13 by LEONE DEBORAH R
  • 4: filed on 2023-05-08 by WEAVER KIRKE
  • 4: filed on 2023-05-08 by WALSH MATTHEW M
  • 4: filed on 2023-05-08 by STAHLER RACHEL A
  • 4: filed on 2023-05-08 by RITTER GERALYN S
  • 4: filed on 2023-05-08 by NISITA VITTORIO
  • 4: filed on 2023-05-08 by MORRISSEY JOSEPH T. JR.
  • 4: filed on 2023-05-08 by MILLIGAN SANDRA

    • Events (8k)

  • 8-K: filed on 2023-11-02:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-08-08:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-07-07:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-08:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2023-05-04:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-02-16:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-12-09:
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-03:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-04:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-12:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    WALSH MATTHEW M CHIEF FINANCIAL OFFICER

    • Officer
    		 52,411 2023-08-05 3

    STAHLER RACHEL A CHIEF INFORMATION OFFICER

    • Officer
    		 31,781 2023-08-05 3

    LAZARUS ROCHELLE B

    • Director
    		 633 2023-06-09 1

    COX CARRIE SMITH

    • Director
    		 0 2023-06-09 1

    ESSNER ROBERT

    • Director
    		 0 2023-06-09 1

    SHARP SHALINI

    • Director
    		 2 2023-06-09 1

    GAYLE HELENE D

    • Director
    		 0 2023-06-09 1

    PATTON CYNTHIA M

    • Director
    		 0 2023-06-09 1

    WHITEFORD GRACE PUMA

    • Director
    		 5 2023-06-09 1

    FRANCISCO MA. FATIMA

    • Director
    		 3,000 2023-06-09 1

    EZEKOWITZ ALAN

    • Director
    		 0 2023-06-09 1

    OZUAH PHILIP

    • Director
    		 0 2023-06-09 1

    MCGARRY MARTHA E

    • Director
    		 0 2023-06-09 1

    LEONE DEBORAH R

    • Director
    		 10 2023-06-09 1

    RITTER GERALYN S HEAD OF EXT. AFFAIRS AND ESG

    • Officer
    		 10,755 2023-05-04 4

    ALI KEVIN CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 50,619 2023-05-04 4

    FALCIONE AARON CHIEF HUMAN RESOURCES OFFICER

    • Officer
    		 14,762 2023-05-04 4

    MORRISSEY JOSEPH T. JR. HEAD OF MANUFACTURING

    • Officer
    		 21,016 2023-05-04 4

    MILLIGAN SANDRA HEAD OF RESEARCH & DEVELOPMENT

    • Officer
    		 28,599 2023-05-04 4

    NISITA VITTORIO HEAD OF GLOBAL BUSINESS SVCS

    • Officer
    		 10,886 2023-05-04 4

    FIEDLER SUSANNE CHIEF COMMERCIAL OFFICER

    • Officer
    		 25,191 2023-05-04 4

    DIMARCO KATHRYN CORPORATE CONTROLLER

    • Officer
    		 7,517 2023-05-04 3

    WEAVER KIRKE GEN. COUNSEL & CORP. SECY.

    • Officer
    		 12,461 2023-05-04 5

    TELMAN DEBORAH H EVP GC & CORPORATE SECRETARY

    • Officer
    		 12,119 2022-05-04 0

    MERCK & CO., INC.

    • 10% Owner
    		 No longer subject to file 2021-06-02 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    ORGANON & CO OGN 2023-12-01 15:15:05 UTC 4.9119 0.4081 8400000
    ORGANON & CO OGN 2023-12-01 14:45:03 UTC 4.9119 0.4081 8400000
    ORGANON & CO OGN 2023-12-01 14:15:04 UTC 4.9119 0.4081 8400000
    ORGANON & CO OGN 2023-12-01 13:45:04 UTC 4.9119 0.4081 8400000
    ORGANON & CO OGN 2023-12-01 13:15:04 UTC 4.9119 0.4081 8400000
    ORGANON & CO OGN 2023-12-01 12:45:04 UTC 4.9119 0.4081 8400000
    ORGANON & CO OGN 2023-11-30 22:15:04 UTC 4.9119 0.4081 8600000
    ORGANON & CO OGN 2023-11-30 21:45:04 UTC 4.9119 0.4081 8600000
    ORGANON & CO OGN 2023-11-30 21:15:05 UTC 4.9119 0.4081 8600000
    ORGANON & CO OGN 2023-11-30 20:45:05 UTC 4.9119 0.4081 8600000
    ORGANON & CO OGN 2023-11-30 20:16:16 UTC 4.9119 0.4081 8600000
    ORGANON & CO OGN 2023-11-30 19:45:03 UTC 4.9119 0.4081 8600000
    ORGANON & CO OGN 2023-11-30 19:15:04 UTC 4.9119 0.4081 8600000
    ORGANON & CO OGN 2023-11-30 18:45:04 UTC 4.9119 0.4081 8600000
    ORGANON & CO OGN 2023-11-30 18:15:04 UTC 4.9119 0.4081 8600000
    ORGANON & CO OGN 2023-11-30 17:45:04 UTC 4.9119 0.4081 8600000
    ORGANON & CO OGN 2023-11-30 17:15:04 UTC 4.9119 0.4081 8600000
    ORGANON & CO OGN 2023-11-30 16:45:03 UTC 4.9119 0.4081 8600000
    ORGANON & CO OGN 2023-11-30 16:15:04 UTC 4.9119 0.4081 8500000
    ORGANON & CO OGN 2023-11-30 15:45:04 UTC 4.9119 0.4081 8500000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Weiss Strategic Interval Fund- Weiss Strategic Interval Fund OGN -29181.0 shares, $-682835.4 2022-09-30 N-PORT
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund OGN -4200.0 shares, $-72912.0 2023-09-30 N-PORT
    Siren ETF Trust- Siren DIVCON Dividend Defender ETF OGN -4944.0 shares, $-85827.84 2023-09-30 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments